key: cord-0832570-uko6zyvx
authors: Vesga, O.; Agudelo, M.; Valencia-Jaramillo, A. F.; Mira-Montoya, A.; Ossa-Ospina, I. F.; Ocampo, E.; Ciuoderis, K.; Perez, L.; Cardona, A.; Aguilar, Y.; Agudelo, Y.; Hernandez-Ortiz, J. P.; Osorio, J. E.
title: Highly sensitive scent-detection of COVID-19 patients in vivo by trained dogs
date: 2021-06-07
journal: nan
DOI: 10.1101/2021.05.30.21257913
sha: aa05fb4c7f509811ad2d94597ef459b24a401858
doc_id: 832570
cord_uid: uko6zyvx

Timely and accurate diagnostics are essential to fight the COVID-19 pandemic, but no test satisfies both conditions. Dogs can scent-identify the unique odors of the volatile organic compounds generated during infection by interrogating specimens or, ideally, the body of a patient. After training 6 dogs to detect SARS-CoV-2 in human respiratory secretions (in vitro scent-detection), we retrained 5 of them to diagnose the infection by scenting the patient directly (in vivo scent-detection). Then, efficacy trials were designed to compare the diagnostic performance of the dogs against that of the rRT-PCR in 848 human subjects: 269 hospitalized patients (COVID-19 prevalence 30.1%), 259 hospital staff (prevalence 2.7%), and 320 government employees (prevalence 1.25%). The limit of detection in vitro was lower than 10-12 copies ssRNA/mL. In vivo, all dogs detected 92 COVID-19 patients present among the 848 study subjects. Detection was immediate, and independent of prevalence, time post-exposure, or presence of symptoms, with 95.2% accuracy and high sensitivity (95.9%; 95% C.I. 93.6-97.4), specificity (95.1%; 94.4-95.8), positive predictive value (69.7%; 65.9-73.2), and negative predictive value (99.5%; 99.2-99.7). To determine real-life performance, we waited 75 days to carry out an effectiveness assay among the riders of the Metro System of Medellin, deploying the human-canine teams without previous training or announcement. Three dogs (one of each breed) scent-interrogated 550 citizens who volunteered for simultaneous canine and rRT-PCR testing. Negative predictive value remained at 99.0% (95% C.I. 98.3-99.4), but positive predictive value dropped to 28.2% (95% C.I. 21.1-36.7). Canine scent-detection in vivo is a highly accurate screening test for COVID-19, and it detects more than 99% of infected individuals independently of the key variables. However, real-life conditions increased substantially the number of false positives, indicating the necessity of training a threshold for the limit of detection to discriminate environmental odoriferous contamination from infection.

experimentally induced infections or after very close contact with an infected owner, the 101 medical screening can be a very boring task for the dog, and most experts agree that the 124 ideal dog for scent-detection must display superlative amounts of motivation, stamina, 125 determination, and resilience [14, 15] . Animal behavior scientists avoid this 126 anthropomorphic jargon, but cognition research is providing solid evidence that dogs 127 indeed have unusual minds compared with other nonhuman animals, and that such 128 advantage comes from sharing their lives with us [30] . 129

The principal objective of this study was to determine the performance of scent-detection 131 dogs as a screening tool in vivo for immediate detection of COVID-19 patients under a 132 variety of circumstances [31] . The design aimed at answering five research questions: One, 133 if working dogs with the above-mentioned attributes, but belonging to breeds created for 134 tasks other than olfaction, would succeed as medical detectors; a positive result would 135 increase significantly the canine population from which dogs could be selected. Two, the 136 minimal number of COVID-19 patients required to train the dogs in vitro; such number 137 must be enough for the dogs to make the inference that any human being with the same 138 smell-print is a positive. Three, the size effects of the diagnostic metrics in vitro and in vivo 139 under controlled experimental conditions, i.e., efficacy. Four, the canine limit of detection, 140 in copies of single stranded viral RNA per milliliter (ssRNA/mL). And five, the real-life 141 performance of the dogs in vivo, i.e., screening effectiveness. 142 143 Design and sample size 144 Screening and diagnostic tests differ in their applications, and validation of the former 145 requires a much smaller sample size [32] . In order to produce dogs capable of screening 146 humans for SARS-CoV-2 infection, teaching them to identify the virus in vitro was a 147 mandatory prerequisite. The first step was to ask written informed consent from 12 patients 148 hospitalized with COVID-19 to aliquot and ultra-freeze (-70°C) their respiratory secretions. 149

The specimens were thawed and used as needed. Demographic information of the 150 participants who provided specimens for phases 1 and 2 can be seen in Table 1. The  151 training work was planned in three phases, each followed by its corresponding 152 experimental aspect (Fig 1) . Phase 1 ("in vitro recognition) lasted 28 days during which we 153 trained the dogs to recognize in vitro the scent-print of SARS-CoV-2 under a wide variety 154 of environmental modifications. One aspect of training that remained constant was the 155 error-free discrimination learning protocol developed by Terrace [33] , which consists in 156 always presenting the animal a marked contrast between positive and negative stimuli [34] . 157

The "stimulus" is the problem presented to the dog, which was, for in vitro diagnosis, 158 sterile saline solution (phase 1) or human saliva (phases 2), and for in vivo screening, the 159 body of a person. A stimulus can be "positive" when it leads to a reward (SARS-CoV-2), or 160 "negative", if it does not represent a reward for the dog (controls). To recognize SARS-161

CoV-2, we trained the dogs to find their food (the reward) using their olfaction, always 162 hiding with it a respiratory specimen from Patient 1 (the positive stimuli). The amount of 163 food was diminished progressively until only the SARS-CoV-2 specimen was left in the 164 hiding place, while the number of hides with saline increased in number. We marked the 165 correct behavior (i.e., identification of SARS-CoV-2) pressing a clicker device, and 166 immediately rewarded the dog. It took one day for all dogs to understand that finding the 167 SARS-CoV-2 specimen meant a prize for them, and that saline conveyed no reward. The 168 following 27 days of the first phase the dogs were trained with respiratory secretions from 169 Patients 1, 2 and 3 under the above-mentioned variations, but keeping constant the negative 170 stimuli (saline). The other 9 positive specimens (Patients 4-12) were reserved exclusively 171 for experimentation, which only took place after training in each of the first two phases had 172 taught the dogs the error-free skills necessary to identify SARS-CoV-2 with Patients 1-3. 173 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 7, 2021. experiments, introducing a more difficult scenario by minimizing prevalence during phase 2 (in vitro 185 diagnosis). Prevalence during phase 3 (in vivo diagnosis) was spontaneous, given by the pandemic 186 epidemiology in our hospital, which is a large reference institution.

During phase 2 ( "in vitro diagnosis"), we trained the dogs for 21 days keeping constant the 189 positive stimuli (specimens from Patients 1, 2 and 3), but changing the negative stimuli for 190 human saliva specimens donated by 100 human volunteers (Patients 13-112, Table 1 ). 191

These 100 donors were healthy, ambulatory people belonging to the general population, 192 whose saliva specimens were negative for SARS-CoV-2 by rRT-PCR the same day that we 193 aliquoted and froze them at -70ºC (collection took place in March 2020, when the 194 pandemic was just starting in Colombia). To prevent replication of the microbiota within 195 each saliva sample, working specimens were thawed and kept at 4ºC between uses, and 196 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 7, 2021. canines were trained to detect the odor print of SARS-CoV-2 in saliva and in the human 215 body (Fig 2) : four Belgian Shepherd Malinois (a herding breed), one first-generation cross 216

Alaskan Malamute by Siberian Husky (a Nordic sled-dog), and one pit bull (a fighting 217 breed). For every experiment, the position of the samples in the field (1 to 100) and disease 218 prevalence (1% to 10%) were randomized with a mobile phone app. For each in vitro 219 experiment, the dogs went through an open field arrangement of 10 x 10 samples (100) 220 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 7, 2021. ; https://doi.org/10.1101/2021.05.30.21257913 doi: medRxiv preprint distanced 2 m in all directions. An illustration of the experimental field and the scent-221 detection work in vitro can be seen in Video S1. 222 

Generalization (i.e., the dog recognizes the scent-print of SARS-CoV-2 in a specimen from 231 any infected individual) in phases 1 and 2 was achieved with a small set of three COVID-232 positive samples (Patients 1 to 3; Table 1 ). To demonstrate that the dogs knew that they 233 were looking for the scent-print of SARS-CoV-2 instead of the specific scents from the 234 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 7, 2021. ; three individuals used to train them, we used for experimentation after phases 1 and 2 the 235 specimens from Patients 4-12, to which they had never been exposed. The same principle 236 was applied to in vivo screening: we tested the dogs in patients only after obtaining very 237 high diagnostic metrics in vitro. Dogs could scent any part of the anatomy and were 238 allowed to touch with their noses the body of the patients, who were instructed to present 239 their hands opened with palms facing the dog. The relatively long time we spent in training 240 for phase 3 (56 days) had the only objective of eliminating false positives, because 241 recognition of true positives was straightforward. The dogs trained with 400 subjects who 242 did not participate in the experiments: 100 hospitalized patients (40% with COVID-19) and 243 300 health-care workers (7% with COVID-19). These training was done to improve 244 specificity and positive predictive value, because sensitivity and negative predictive value 245 never represented an obstacle. Our focus was in vivo screening, and we used in vitro 246 training and experimentation as means to arrive to our main goal, the canine detection of 247 COVID-19 by scenting the human body. To ensure that the dogs were not fixed on the 248 hospital scent, we obtained saliva samples from each of the 300 health-care workers who 249 volunteered for in vivo training, and made the dogs scent-interrogate saliva once they had 250 finished each training session in vivo: NPV in vitro was close to 100%, and PPV were 251 above 80%, indicating that they were not looking for a scent other than SARS-CoV-2. 252 253 Dog-trainer teams biosafety: evaluation of the SARS-CoV-2 254 containment devices 255 To prevent contagion of canine and human individuals participating in this study with 256 SARS-CoV-2 specimens, we contrived two devices (D1 and D2) made with the fabric of 257 the Dupont TM Tychem 2000. D1 was a used for scent-detection in saliva or respiratory 258 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 7, 2021. ; https://doi.org/10.1101/2021.05.30.21257913 doi: medRxiv preprint specimens; it was a 130-mL glass flask with a metallic lid in which we perforated a 1 cm 259 hole in the middle, and the lid allowed a hermetic closure that remained intact after placing 260 a 10x10 cm piece of Tychem 2000 between the bottle and its lid. D2 was used for the same 261 purpose but offered greater versatility than D1; it was a waterproof bag made of two 18x8 262 cm pieces of Tychem 2000, heat-sealed in its four sides after placing inside it a sterile 263 gauze impregnated with the specimen. 264

In order to determine if any of the dog-trainer teams got infected by, or could have been at 266 risk of exposure to SARS-CoV-2 during the project, were used two approaches: one, 267 running rRT-PCR tests in saliva of dogs and trainers by at the end of the second and third 268 phases; and two, evaluating experimentally the efficiency of our containment devices in the 269 Syrian hamster (Mesocricetus auratus) COVID-19 model ( Fig S1) . After an acclimatization 270 period of 4 weeks, we exposed during four days 15 animals of both sexes (6 females and 9 271 males) to SARS-CoV-2 in groups of 3 animals of the same sex, 2 groups for the 272 experimental arms and 3 groups as control arms, each contained in a HEPA filtered One 273 System cage. Each of the two experimental groups had inside their respective cage one of 274 the containment devices (D1 in group 1, D2 in group 2) protected by a metallic welded wire 275 mesh enclosure that allowed hamsters to smell the contraption without touching it. Each of 276 the three control groups had free access to an unprotected D1 flask (group A), a sterile 277 gauze impregnated with a fresh specimen from a different COVID-19 patient (group B), or 278 and unprotected D2 bag (group C). D1, D2 and the virus-impregnated gauze were replaced 279 with fresh SARS-CoV-2 specimens every 12 hours in the 5 groups. All hamsters were 280 sampled for rRT-PCR by saliva swabs before and after SARS-Cov-2 exposure. 281 282 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 7, 2021. ; https://doi.org/10.1101/2021.05.30.21257913 doi: medRxiv preprint Experimentation after scent-detection training 283 Three kinds of 2-mL specimens were prepared under a biosafety class III laminar flow 284 cabinet using 209 sterile, scent-free flasks. One-hundred flasks had 0.9% sterile saline 285 solution (phase 1, control arm), 100 had rRT-PCR-negative saliva (phase 2, control arm), Before the next search, each dog was scheduled to have an unrestricted play session and to 295 take a long walk with its trainer. Once ready, the field was rearranged for a new experiment 296 changing at random the position of the specimens and the prevalence of COVID-19. 297 298 Although the majority of the experiments related to phase 1 training were unblinded, all 299 experiments for phases 2 and 3 were blinded, i.e., the dog handlers did not know the 300 position and number of positive specimens (phase 2) or patients (phase 3). Such 301 information was managed exclusively by the training director (AFVJ), whom actioned the 302 clicker immediately upon any correct indication by the canine, delivering an unequivocal 303 auditory signal that informed the human-canine team of every correct finding. This design 304 implied that the training director never interacted with the dogs during the experimental 305 process. 306 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 7, 2021.

Immediately after ending experimentation for phase 2, we started phase 3 training at 308 were rigorously checked, we applied the two-tailed Fisher's Exact Test to challenge the null 327 hypothesis that the dogs detected COVID-19 by chance. 328

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 7, 2021. ; https://doi.org/10.1101/2021.05.30.21257913 doi: medRxiv preprint 329 Limit of canine scent-detection 330 Freshly collected saliva specimens from four COVID-19 patients (unknown to the dogs) 331

were serially diluted in sterile physiologic saline solution in 1:10 steps down to 1x10 -12 332 copies ssRNA/mL. The viral loads had been determined beforehand and ranged from 47 to 333 475 copies ssRNA/mL, therefore 15 dilutions were prepared for each of the four specimens. Once the dogs were fully proficient identifying the specimens from Patients 1, 2 and 3 351 without errors, we evaluated their performance experimentally with specimens from 352 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 7, 2021. ; https://doi.org/10.1101/2021.05.30.21257913 doi: medRxiv preprint patients to which they had not been exposed (Patients 4 to 12, Table 1 ). In phase 1, the 353 number of experiments varied for each dog because the required sample size (3200) was 354 reached early, all six recognized COVID-19 specimens with accuracy >95.0%, and we tried 355 to minimize the dog's exposure to the specimens from each of the 9 patients. The mean 356 prevalence of SARS-CoV-2 positive samples for these experiments was 7.56% (range, 357 5.0%-8.6%), and the effect sizes were very high for each of the six dogs (Table S2) After phase 2 training with specimens from Patients 1-3 (positive stimuli) and 13-112 367 (negative stimuli) under a prevalence no greater than 4%, diagnostic performance was 368 determined experimentally with saliva from Patients 4-12 (experimental arm) disguised at 369 an average prevalence of 2.2% among saliva samples from healthy volunteers 13-112 370 (control arm). Compared with phase 1, there was a significant improvement in the effect 371 sizes of all metrics for every dog (Table S3) NPV was close to perfection, thereby suggesting a very low probability that any of our dogs 375 would miss a positive case in vitro (Fig S2) . 376 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This response from the dogs proved that saliva from just 12 COVID-19 patients provided 386 enough variety for them to infer that the scent-print of the disease could be found in vivo 387 (as they had learned in vitro), and that marking patients or fomites (contaminated with the 388 target scent-print) as positive was the behavior we were asking from them. That inference 389 was our main training goal, but it was evident from day 1 that all training during phase 3 390 had to focus in reducing false positives, because the scent-print of COVID-19 was spread 391 throughout the surfaces of HUSVF, and the dogs detected it everywhere. To determine the 392 reason, we moved training to the Emergency Room (ER), which is not only the port of 393 entry for all patients, but also the busiest and most crowded service of our institution. In 394 hospitalization wards we obtained the rRT-PCR results ahead of the training session, but it 395 was impossible in the ER because patients were admitted the same day of training and 396 results came afterwards. In three independent training sessions with 50-60 patients each, we 397 found that 10% of the ER population was made of asymptomatic COVID-19 patients that 398 had passed undiagnosed after being admitted for other reasons, mostly traumatic injuries. 399

These patients were being admitted in the different surgical and medical wards, 400 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. conditions were closely controlled for the three groups, which demographics are described 410

in Table 2 . 411 412 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 7, 2021. ; 

Before canine scent-interrogation, we sampled the 848 participants to determine their 418 COVID-19 status by molecular and antigen testing (Fig 3) . COVID-19 was confirmed in 92 419 patients (10.85%) and discarded in 753 (88.8%). The other 3 (0.35%) were asymptomatic 420 subjects with "indeterminate" rRT-PCR results after repeated testing, and had to be 421 excluded from the analysis (Fig 4) . The average cycle threshold (C T ) of the rRT-PCR 422 positive patients was 32.0 (range, 20.6-38.8). COVID-19 was diagnosed by antigen test 423 (Standard Q COVID-19 Ag Test, SD Biosensor) in 51 patients that had bee admitted to the 424 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 7, 2021. (Table 3) . Individual performance mirrored closely the group 436 metrics (Fig 5) . Four of 320 participants in the low-risk group had positive rRT-PCR tests 437 (prevalence 1.25%), but none did show up for the canine scent test. It produced zero values 438 in two cells of the 2x2 contingency tables, preventing the computation of size effects (Fig  439   4) . 440 441 442 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 7, 2021. ; . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 7, 2021. ; 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 7, 2021. ; 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 7, 2021. (Table 4, Fig 6) , but the dogs adjusted within hours to the new environment and 488 improved their performance until reaching a plateau (Fig 7) . 489 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 7, 2021. 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 7, 2021. ;

In vivo screening (effectiveness assay). Performance metrics of three dogs 503

in the Metro System of Medellin; prevalence, 3.1%. Each symbol has a different color to ease 504 visualization of the dogs. The vertical lines above and below the symbols represent the 95% confidence 505 interval for each metric, which is contained within the symbol for NPV and ACC. 506 507 508 509 510 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 7, 2021. ; https://doi.org/10.1101/2021.05.30.21257913 doi: medRxiv preprint Limit of canine scent-detection 519 The LOD was determined in vitro using freshly collected saliva specimens from four 520 COVID-19 patients new to the dogs. The moment of this assay coincided with the estrus 521 cycle of several females, which caused the exclusion of the males from this experiment 522 because both refused to work. The LOD for Andromeda, Nina, Vika, and Vita was lower 523 than 2.61 x 10 -12 copies ssRNA/mL (Table S4) , the equivalent of detecting a drop (0.05 524 mL) of any odorous substance dissolved in a volume of water greater than the capacity of 525 10.5 Olympic swimming pools (2.6x10 10 mL). 526 527 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 7, 2021. ; https://doi.org/10.1101/2021.05.30.21257913 doi: medRxiv preprint 528 None of the dogs, their trainers, or the physician-scientists in charge of sampling and taking 529 care of the patients contracted COVID-19 during this study. The rRT-PCR tests for SARS-530

CoV-2 from canines and humans resulted negative twice, once after ending the in vitro 531 phase, and again after finishing the in vivo phase of the study (Table S5) . Experimental 532 testing of the contraptions to contain SARS-CoV-2 showed that both devices worked as 533 intended, allowing the scent to evaporate while holding the virus secured inside (Fig 8) . 534

Test hamsters climbed and smelled the mesh-protected contraptions D1 (group 1) and D2 535 (group 2), but no animal contracted SARS-CoV-2. Control hamsters group A did climb on 536

D1but could not damage the Tychem 2000 fabric covering the flask, and none got infected; 537 group C did bite the Tychem of D2, and 1 animal was infected; and group B played, bit, 538 nested, and slept in the gauze impregnated with SARS-CoV-2, and the three hamsters in the 539 cage acquired SARS-CoV-2 (Table S6) . 540 541 542 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 7, 2021. ; is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 7, 2021. (just three in this case) could lead the dog to learn by memory the scent-print of the 605 individuals instead of that of the virus, and that "at least a hundred" positive donors are 606 needed [46] . We found that such belief is unfounded: on the one hand, our dogs identified 607 the positive specimens of 9 unknown patients in phase 2, and almost all 105 patients 608 infected by SARS-CoV-2 in phase 3. On the other hand, research on the concept of 609 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 7, 2021. ; https://doi.org/10.1101/2021.05.30.21257913 doi: medRxiv preprint working memory demonstrated that expert detection dogs remembered a new scent-print 610 98% of the time as long as it was located first in a line-up with five distractors, but 611 performance went down when the positive stimulus was located farther, dropping to 11.5% 612 at the sixth location [29] . Therefore, it seems impossible for a dog to remember the odor of 613 up to 12 different individuals randomly allocated among 100 distractors. These data suggest 614 that dogs are not relying in memory when they detect SARS-CoV-2 and discriminate it 615 among so many other odoriferous cues. Although nasopharyngeal swabs were first established as the method of choice to take the 627 specimens for rRT-PCR for SARS-CoV-2, we used saliva because there is solid evidence 628 demonstrating that it is more sensitive than nasopharyngeal swabs [53], sampling is faster 629 and much easier, the need for sterile swabs is eliminated as well as the uncomfortable 630 introduction of a foreign object through the nose of the patient and, contrary to the 631 nasopharynx, the viral loads in saliva predict severity [54] . Also, we refrained from using 632 saliva from non-COVID hospitalized patients as negative stimuli to adhere to error-free 633 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 7, 2021. SARS-CoV-2 or, even less, from other non-human coronavirus. Since human coronavirus 644 usually cause mild upper respiratory infections, these patients rarely need hospitalization 645 and were not part of our sample. We did find that none of the 43 hospitalized patients with 646 respiratory conditions other than COVID-19 was positive for the dogs despite the fact that 647 half of them had pneumonia caused by bacterial or viral pathogens like influenza virus. 648

Second, the dogs did not have the opportunity to scent-interrogate any of the four COVID-649 19 subjects from the low-risk group because they relinquished that part of the study. This 650 prevented statistical calculations necessary to determine the size effects of the different 651 performance metrics under very low prevalence (1.25%). The third limitation arose during 652 dog training, and it caused the sharp decline in PPV from 69.7% to 28.2% between efficacy 653 and effectiveness trials. To improve PPV, it is necessary to teach the dogs that there is a 654 cut-off value in odor intensity below which they should disregard the COVID-19 scent-655 print. However, more research is needed to identify such threshold value and to know if it 656 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 7, 2021. ; https://doi.org/10.1101/2021.05.30.21257913 doi: medRxiv preprint is worth to train for that, because it might be an asset to have dogs that can detect the virus 657 immediately after a patient gets contaminated with it. 658 659 After our preprint [58] , at least four studies on canine scent-detection of SARS-CoV-2 in 660 vitro have been formally published [59-63], and despite substantial methodological 661 differences with our work, results are reproducible. The main difference with those studies 662 is that we chose to scent-interrogate the human body instead of a specimen, and did it 663 because of the many obvious advantages that such approach brings: results are immediate, 664

can be obtained anywhere, do not require equipment, and allow in situ separation of 665 contagious individuals. The use of trained dogs as medical detectors was safe for the human 666 participants during training and experimentation regardless of the breed, a point of major 667 importance considering that deployment would require the participation of many canines 668 [64, 65] , and the possibility of training dogs for real-time diagnosis of many other 669 infectious diseases may help humanity be better prepared to confront the next pandemic 670

[66]. These data suggest that well-trained dogs may aid the safe re-opening of economies 671 and educational systems, while offering an efficient way to control the pandemic. 672 673

Testing in a Pandemic -Improving Access

Asymptomatic transmission, the Achilles' heel of 681 current strategies to control Covid-19

Variation in false-negative 683 rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by 684 time since exposure

Interim guidelines for rapid antigen testing 686 for SARS-CoV-2

Interim guidelines for COVID-19 antibody 689 testing

Countries beating COVID-19

Covid Lockdown Cost/Benefits: A Critical Assessment of the Literature

The Economic Impact of Lockdowns: A 696

BNT162b2 mRNA 699

Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

CoV-2 variants B.1.351 and B.1.1.7. Nature

Challenges of "return to work" in an ongoing pandemic

The invaders: how humans and their dogs drove Neanderthals to 707 extinction

Romanes GJ. Experiments on the sense of smell in dogs

Canine olfaction science and law: advances 710 in forensic science, medicine, conservation, and environmental remediation

Canine ergonomics: the science of working dogs

Doctor dogs: how our best friends are becoming our best medicine

Smelling the diagnosis. A review on the use of 717 scent in diagnosing disease

Sniffing animals as a diagnostic tool in infectious diseases

Canine olfactory 724 detection of a vectored phytobacterial pathogen, Liberibacter asiaticus, and integration 725 with disease control

Canine olfactory 727 detection of a non-systemic phytobacterial citrus pathogen of international quarantine 728 significance

Canine detection of 730 the volatilome: a review of implications for pathogen and disease detection

Breath-borne VOC Biomarkers for 733

Broad host 737 range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in 738 vertebrates

Experimental infection of domestic dogs and cats with SARS-CoV-2: Pathogenesis

transmission, and response to reexposure in cats

Animal Intelligence: Experimental Studies

Performance decline by search dogs in repetitive tasks, and mitigation strategies

The advent of canine performance 749 science: offering a sustainable future for working dogs

Canine olfaction: scent, sign, and situation

Domestic dog cognition and behavior: the scientific study of Canis familiaris

Is cognition the secret to working dog success? Anim Cogn

STARD 757 2015: an updated list of essential items for reporting diagnostic accuracy studies

Requirements for minimum sample size for sensitivity and 760 specificity analysis

Terrace HS. Discrimination learning with and without "errors

Terrace HS. Wavelength generalization after discrimination learning with and without 765 errors

Statistical power analysis for the behavioral sciences

Erlbaun Associates

SARS-CoV-2) is comparable in clinical 771 samples preserved in saline or viral transport medium

Consultation on Critical Issues in Diagnostic Testing for the COVID-19 Pandemic 775

Rethinking Covid-19 test sensitivity -A strategy 778 for containment

SARS-CoV-2 virus 781 transfers to skin through contact with contaminated solids

False negative tests for SARS-CoV-2 infection -785 challenges and implications

Naturalistic 787 quantification of canine olfactory sensitivity

Trainability and boldness traits differ between dog 789 breed clusters based on conventional breed categories and genetic relatedness

A solution for the shortage 792 of detection dogs: a detector dog center of excellence and a cooperative breeding 793 program

Wildlife detection dog training: A case 795 study on achieving generalization between target odor variations while retaining 796 specificity

Olfactory generalization in detector dogs

Border collie comprehends object names as verbal referents

Depths and limits of spontaneous categorization in a family 806 dog

Border collie comprehends sentences containing a prepositional object, verb, 808 and direct object

The genius of dogs -How dogs are smarter than you think. New 810 York: Dutton

Saliva or nasopharyngeal swab specimens for detection of SARS-813

Saliva viral load is a 815 dynamic unifying correlate of COVID-19 severity and mortality. medRxiv

Animal cognition and the new anthropomorphism

The human intestinal microbiome in health and disease. N Engl 820

Metagenomic 822 analysis reveals dynamic changes of whole gut microbiota in the acute phase of 823 intensive care unit patients

Alterations in gut 825 microbiota of patients with COVID-19 during time of hospitalization

Dog savior: 828 immediate scent-detection of SARS-COV-2 by trained dogs

Discrimination 840 of SARS-CoV-2 infected patient samples by detection dogs: A proof of concept study

Could 843 bio-detection dogs be used to limit the spread of COVID-19 by travellers

Toward the use of medical scent detection dogs for COVID-19 846 screening

Breed differences in canine aggression

Aggressive 850 behaviour is affected by demographic, environmental and behavioural factors in 851 purebred dogs

The case for No-COVID

We thank sincerely the patients and staff of HUSVF and the officers of the Governor of 675 Antioquia for participating in the study. 676

and signed their informed consent. We did not subject our dogs to any kind of pressure for 880 training. We did not starve the dogs and did not need to make them fanatics for food, toys, 881 games, or anything else. Since it is impossible to force a dog to do scent-work, our methods 882 are exclusively positive, rewarding every correct response, and being indifferent to any 883 mistake. 884 885 886